상세 보기
Continued Treatment Beyond Progression with Zenocutuzumab, a HER2/HER3 Bispecific Antibody, in Patients with NRG1+NSCLC: Analysis from the Ongoing Phase 2 eNRGy Trial
- Arter, Zhaohui Liao;
- Schram, Alison M.;
- Rha, Sun Young;
- Goto, Koichi;
- Tsang, Erica S.;
- ... Park, Joon O.;
- 외 15명
Citations
WEB OF SCIENCE
0- 제목
- Continued Treatment Beyond Progression with Zenocutuzumab, a HER2/HER3 Bispecific Antibody, in Patients with NRG1+NSCLC: Analysis from the Ongoing Phase 2 eNRGy Trial
- 저자
- Arter, Zhaohui Liao; Schram, Alison M.; Rha, Sun Young; Goto, Koichi; Tsang, Erica S.; Kim, Dong-Wan; Duruisseaux, Michael; Springfeld, Christoph; Hallak, Al Mohammed Najeeb; Rodon, Jordi; Wislez, Marie; Morizane, Chigusa; Park, Joon O.; Yang, James Chih-Hsin; Neuzillet, Cindy; Nishino, Kazumi; Ragsdale, Carolyn E.; Garner, Fiona; Adeyemi, Shola; Jauhari, Shekeab; Nagasaka, Misako
- 발행일
- 2026-07
- 유형
- Meeting Abstract
- 권
- 21
- 호
- 7
- 페이지
- S10 ~ S11
- 언어
- ENG
- 출판사
- ELSEVIER SCIENCE INC
- 발행국가
- 미국
- ISSN
- E 1556-1380
P 1556-0864